Duchenne muscular dystrophy (DMD) is a disorder that alter the expression of the dystrophin protein. Dystrophin deficiency alters the structural integrity of the contractile apparatus/sarcolemmal integrity, leading to dystrophic changes. Dystrophin deficiency results in an increase in oxidative stress. We aimed to investigate the thiol/disulfide balance as an oxidative stress marker in children with DMD. We included 24 DMD, and 22 healthy control group subjects in the study. The total thiol, native thiol, and disulphide levels were measured and the disulphide/native thiol, disulphide/total thiol and native thiol/total thiol ratios were calculated in DMD patients and healthy subjects. The mean age distribution of the patients and the healthy control group subjects was similar. The total thiol, native thiol, and disulfide levels were lower in DMD group than the healthy controls. In conclusion, the markers and ratios were measured and calculated in the blood, and we detected that the total thiol, and native thiol levels were lower in DMD group than the healthy controls. These results indicate that dynamic thiol-disulphide homeostasis can be used as a marker of oxidative stress in clinical trials with DMD.
This is a preview of subscription content, log in to check access.
The authors received no financial support for the research, authorship, and/or publication of this article.
Compliance with ethical standards
Conflict of interest
The authors declared no potential conflict of interest with respect to the research, authorship, and/or publication of this article.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent was obtained from the parents of the child included in the study.
Bonilla E, Samitt CE, Miranda AF et al (1988) Duchenne muscular dystrophy: deficiency of dystrophin at the muscle cell surface. Cell 54:447–452CrossRefGoogle Scholar
Ragusa R, Chow C, Porter J (1997) Oxidative stress as a potential pathogenic mechanism in an animal model of Duchenne muscular dystrophy. Neuromuscul Disord 6:379–386CrossRefGoogle Scholar
Disatnik MH, Chamberlain JS, Rando TA (2000) Dystrophin mutations predict cellular susceptibility to oxidative stress. Muscle Nerve 23:784–792CrossRefGoogle Scholar
Haycock JW, MacNeil S, Jones P, Harris JB, Mantle D (1996) Oxidative damage to muscle protein in Duchenne muscular dystrophy. Neuroreport 8:357–361CrossRefGoogle Scholar
Rodriguez MC, Tarnopolsky MA (2003) Patients with dystrophinopathy show evidence of increased oxidative stress. Free Radic Biol Med 34:1217–1220CrossRefGoogle Scholar
Nakae Y, Stoward PJ, Kashiyama T et al (2004) Early onset of lipofuscin accumulation in dystrophin-deficient skeletal muscles of DMD patients and mdx mice. J Mol Histol 35:489–499CrossRefGoogle Scholar
Pinniger G, Terrill J, Assan E, Grounds M, Arthur P (2017) Pre-clinical evaluation of N-acetylcysteine reveals side effects in the mdx mouse model of Duchenne muscular dystrophy. J Physiol 595:7093–7107CrossRefGoogle Scholar
Altıparmak IH, Erkuş ME, Sezen H et al (2016) The relation of serum thiol levels and thiol/disulphide homeostasis with the severity of coronary artery disease. Kardiol Pol 74:1346–1353CrossRefGoogle Scholar
Ateş I, Kaplan M, Yüksel M et al (2016) Determination of thiol/disulphide homeostasis in type 1 diabetes mellitus and the factors associated with thiol oxidation. Endocrine 51:47–51CrossRefGoogle Scholar
Gumusyayla S, Vural G, Bektas H, Neselioglu S, Deniz O, Erel O (2016) A novel oxidative stress marker in migraine patients: dynamic thiol-disulphide homeostasis. Neurol Sci 37:1311–1317CrossRefGoogle Scholar
Tidball JG, Wehling-Henricks M (2007) The role of free radicals in the pathophysiology of muscular dystrophy. J Appl Physiol 102:1677–1686CrossRefGoogle Scholar
Reid MB, Durham WJ (2002) Generation of reactive oxygen and nitrogen species in contracting skeletal muscle: potential impact on aging. Ann NY Acad Sci 959:108–116CrossRefGoogle Scholar
Abdel SE, Abdel-Meguid I, Korraa S (2007) Markers of oxidative stress and aging in Duchene muscular dystrophy patients and the possible ameliorating effect of He:Ne laser. Acta Myol 26:14–21Google Scholar
Chahbouni M, Escames G, López LC et al (2011) Melatonin treatment counteracts the hyperoxidative status in erythrocytes of patients suffering from Duchenne muscular dystrophy. Clin Biochem 44:853–858CrossRefGoogle Scholar
Renjini R, Gayathri N, Nalini A, Srinivas Bharath MM (2012) Oxidative damage in muscular dystrophy correlates with the severity of the pathology: role of glutathione metabolism. Neurochem Res 37:885–898CrossRefGoogle Scholar
Sen CK, Packer L (2000) Thiol homeostasis and supplements in physical exercise. Am J Clin Nutr 72:653–669CrossRefGoogle Scholar
Turell L, Radi R, Alvarez B (2013) The thiol pool in human plasma: the central contribution of albumin to redox processes. Free Radic Biol Med 65:244–253CrossRefGoogle Scholar
Go Y-M, Jones DP (2011) Cysteine/cystine redox signaling in cardiovascular disease. Free Radic Biol Med 50:495–509CrossRefGoogle Scholar
Jones DP, Liang Y (2009) Measuring the poise of thiol/disulfide couples in vivo. Free Radic Biol Med 47:1329–1338CrossRefGoogle Scholar
Erel O, Neselioglu S (2014) A novel and automated assay for thiol/disulphide homeostasis. Clin Biochem 47:326–332CrossRefGoogle Scholar
Kaplan M, Ates I, Yuksel M, Ozderin Ozin Y, Alisik M, Erel O, Kayacetin E (2017) Thiol/disulphide homeostasis in celiac disease. World J Gastrointest Pharmacol Ther 8:120–126CrossRefGoogle Scholar
Kurt ANC, Demir H, Aydin A, Erel Ö (2018) Dynamic thiol/disulphide homeostasis in children with febrile seizure. Seizure 59:34–37CrossRefGoogle Scholar